Chemomab Therapeutics (CMMB) Non Operating Income (2011 - 2026)
Chemomab Therapeutics' Non Operating Income came in at $76,000 for Q2 2026, down 62.9% from $205,000 a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Non Operating Income (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Chemomab Therapeutics reported Non Operating Income of $154,000, down 55.5% year-over-year; for FY2025, it was -$572,000.
- Going back by year, Non Operating Income was -$794,000 in FY2024, -$1.24 million in FY2023, -$353,000 in FY2022 and $111,000 in FY2021.
- The five-year range for quarterly Non Operating Income is -$431,000 (Q4 2023) to $317,000 (Q1 2023).
- Year-over-year, Non Operating Income increased in 1 of the last five quarters, with an average decline of 26.1%.
- Business Quant data shows CMMB's Non Operating Income at $77,000 (Q1 2026), -$101,000 (Q4 2025) and $102,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Chemomab Therapeutics | 7.49 Mn | -27.66 Mn | - | 76,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Sep 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 164,000.00 |
| Dec 31, 2024 | -250,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Mar 31, 2024 | 180,000.00 |
| Dec 31, 2023 | -431,000.00 |
| Sep 30, 2023 | -231,000.00 |
| Jun 30, 2023 | 259,000.00 |
| Mar 31, 2023 | 317,000.00 |
| Dec 31, 2022 | -380,000.00 |
| Sep 30, 2022 | -237,000.00 |
| Jun 30, 2022 | 480,000.00 |
| Jun 30, 2019 | -2.77 Mn |
| Dec 31, 2018 | -1.33 Mn |
| Jun 30, 2018 | 806,000.00 |
API Access
Chemomab Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();